Application of high-sensitivity reagent to the Dade Dimension XL for the determination of cholesterol in high-density and low-density lipoprotein serum fractions

被引:0
|
作者
Artiss, JD
Capellari, E
Warnick, GR
Zak, B
机构
[1] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA
[2] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA
[3] DMC Univ Labs, Detroit, MI 48201 USA
[4] Pacific Biometr Inc, Seattle, WA 98119 USA
关键词
analysis; instrumentation; methods; blood; cholesterol; lipoproteins; high-density; low-density lipoproteins;
D O I
10.1006/mchj.1998.1640
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
We have applied a reagent for the determination of cholesterol in high- and low-density lipoprotein (HDL and LDL) fractions to the Dade Dimension XL automated chemistry analyzer. This reagent has an inherent sensitivity that is four times greater than those of the more common reagents that use phenol or hydroxybenzoate in their indicator reaction. The enhanced sensitivity resulting from the generated chromogen with a higher absorptivity facilitates improved precision, when measuring the small amounts of cholesterol that are recovered from the HDL and LDL fractions of serum. The proposed application correlates well with the Centers for Disease Control reference method. Total imprecision. including the serum fractionation, was <5% within run and <5% day to day. Furthermore, the liquid stable reagent has extended onboard stability and thus requires infrequent calibration. (C) 1998 Academic Press.
引用
收藏
页码:67 / 74
页数:8
相关论文
共 50 条
  • [21] Genes Associated with Low Serum High-density Lipoprotein Cholesterol
    Ahmadzadeh, Alireza
    Azizi, Fereidoun
    ARCHIVES OF IRANIAN MEDICINE, 2014, 17 (06) : 444 - 450
  • [22] SERUM CHOLESTEROL, LOW-DENSITY LIPOPROTEIN, HIGH-DENSITY LIPOPROTEIN, AND TRIGLYCERIDE LEVELS IN SEVERE AND NON-SEVERE ASTHMA
    Linga, Pranavi
    Reyad, Amira
    Pistenmaa, Carrie L.
    Salciccioli, Justin D.
    Haley, Kathleen J.
    Israel, Elliot
    CHEST, 2023, 164 (04) : 5035A - 5037A
  • [24] Comparison of soymilk and probiotic soymilk effects on serum high-density lipoprotein cholesterol and low-density lipoprotein cholesterol in diabetic Wistar rats
    Babashahi, Mina
    Mirlohi, Maryam
    Ghiasvand, Reza
    Azadbakht, Leila
    ARYA ATHEROSCLEROSIS, 2015, 11 : 88 - 93
  • [25] CHOLESTEROL IN SERUM HIGH-DENSITY LIPOPROTEIN FRACTION
    SCHATZ, C
    JEANBLANC, B
    OFFNER, M
    NOUVELLE PRESSE MEDICALE, 1980, 9 (44): : 3339 - 3342
  • [26] Predictive Value of Low-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio for the Prevention of Stroke Recurrence
    Igase, Michiya
    Kohara, Katsuhiko
    Miki, Tetsuro
    NEUROLOGY, 2011, 76 (09) : A630 - A630
  • [27] Blood Rheology and the Low-density Lipoprotein Cholesterol/High-density Lipoprotein Cholesterol Ratio in Dyslipidaemic and Normolipidaemic Subjects
    Machida, T.
    Sumino, H.
    Fukushima, M.
    Kotajima, N.
    Amagai, H.
    Murakami, M.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2010, 38 (06) : 1975 - 1984
  • [28] Association of the Low-density Lipoprotein Cholesterol/High-density Lipoprotein Cholesterol Ratio with Glecaprevir-pibrentasvir Treatment
    Akutsu, Noriyuki
    Sasaki, Shigeru
    Matsui, Takeshi
    Akashi, Hirofumi
    Yonezawa, Kazuhiko
    Ishigami, Keisuke
    Tsujisaki, Masayuki
    Isshiki, Hiroyuki
    Yawata, Atsushi
    Yamaoka, Satoshi
    Ban, Toshihiro
    Adachi, Takeya
    Nakahara, Seiya
    Takagi, Hideyasu
    Nakachi, Kohei
    Tanaka, Katsunori
    Hirano, Takehiro
    Yamamoto, Itaru
    Kaneto, Hiroyuki
    Wagatsuma, Kohei
    Numata, Yasunao
    Nakase, Hiroshi
    INTERNAL MEDICINE, 2021, 60 (21) : 3369 - 3376
  • [29] Joint effect of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol on the risk of coronary heart disease
    Hu, Gang
    Cui, Yadong
    Jousilahti, Pekka
    Sundvall, Jouko
    Girman, Cynthia J.
    Antikainen, Riitta
    Laatikainen, Tiina
    Tuomilehto, Jaakko
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2013, 20 (01) : 89 - 97
  • [30] Chronic intravenous aminobisphosphonate therapy increases high-density lipoprotein cholesterol and decreases low-density lipoprotein cholesterol
    Adami, S
    Braga, V
    Guidi, G
    Gatti, D
    Gerardi, D
    Fracassi, E
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (03) : 599 - 604